May 23, 2024
National Cancer Institute (NCI)
This Notice informs that, effective immediately, the National Cancer Institute (NCI) is participating in NOT-HL-24-014, "Request for Information (RFI): Critical Challenges and Opportunities For Lymphatic Scientific, Clinical, and Disease Communities."
To document NCIs participation, the following section of NOT-HL-24-014 was modified:
Previously Read
National Heart, Lung, and Blood Institute (NHLBI)
Modified to Read (changes shown in bold italics):
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)
All other aspects of the Notice remain the same.
Please direct all inquiries to:
Elisa Woodhouse, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6220
Email: [email protected]